AFP and neoplasm: However, the current clinical use of RFA depends on the experiences based on the traditional tumor characteristics, like tumor size, tumor numbers, and alpha-fetoprotein (AFP), and whether patients will benefit from pretransplant RFA remains controversial [9–12].